High Attenuation and Immunogenicity of a Simian Immunodeficiency Virus Expressing a Proteolysis-resistant Inhibitor of NF-κB
NF-κB/IκB proteins play a major role in the transcriptional regulation of human immunodeficiency virus, type-1 (HIV-1). In the case of simian immunodeficiency virus (SIV) the cellular factors required for the viral transcriptional activation and replication in vivo remain undefined. Here, we demonst...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2004-01, Vol.279 (3), p.1720-1728 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | NF-κB/IκB proteins play a major role in the transcriptional regulation of human immunodeficiency virus, type-1 (HIV-1). In the case of simian immunodeficiency virus (SIV) the cellular factors required for the viral transcriptional activation and replication in vivo remain undefined. Here, we demonstrate that the p50/p65 NF-κB transcription factors enhanced the Tat-mediated transcriptional activation of SIVmac239. In addition, IκB-αS32/36A, a proteolysis-resistant inhibitor of NF-κB, strongly inhibited the Tat-mediated transactivation of SIVmac239. Based on this evidence, we have generated a self-regulatory virus by endowing the genome of SIV-mac239 with IκB-αS32/36A; the resulting virus, SIVIκB-αS32/36A, was nef-deleted and expressed the NF-κB inhibitor. We show that SIVIκB-αS32/36A was highly and stably attenuated both in cell cultures and in vivo in rhesus macaque as compared with a nef-deleted control virus. Moreover, the high attenuation was associated with a robust immune response as measured by SIV-specific antibody production, tetramer, and intracellular IFN-γ staining of SIV gag-specific T cells. These results underscore the crucial role of NF-κB/IκB proteins in the regulation of SIV replication both in cell cultures and in monkeys. Thus, inhibitors of NF-κB could efficiently counteract the SIV/HIV replication in vivo and may assist in developing novel approaches for AIDS vaccine and therapy. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M309375200 |